Phase IB trial of the Her2/neu peptide (E75) vaccine for optimal dosing in node-negative breast cancer patients

✍ Scribed by E.A. Mittendorf; S. Khoo; Z.A. Dehqanzada; M.T. Hueman; C.E. Storrer; K.A. Harris; C.D. Shriver; S. Ponniah; G.E. Peoples Jr

• Book ID: 116702177
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 88 KB
• Volume: 130
• Category: Article
• ISSN: 0022-4804
• DOI: 10.1016/j.jss.2005.11.156